bis(3,5-dimethyl-1-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]pyrazole);bis(9-methylcarbazole);bis(1-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]imidazole);1-methyl-3-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-2H-imidazol-2-ide;tris(9-methylpyrido[2,3-b]indole);platinum;tetrakis(platinum(2+))

C159H127N28O5Pt5-3 — CID 157469530

IUPACbis(3,5-dimethyl-1-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]pyrazole);bis(9-methylcarbazole);bis(1-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]imidazole);1-methyl-3-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-2H-imidazol-2-ide;tris(9-methylpyrido[2,3-b]indole);platinum;tetrakis(platinum(2+))
SMILESCN1C=CN(c2[c-]c(Oc3[c-]c(-n4cccn4)ccc3)ccc2)[CH-]1.Cc1cc(C)n(-c2[c-]c(Oc3[c-]c(-n4cccn4)ccc3)ccc2)n1.Cc1cc(C)n(-c2[c-]c(Oc3[c-]c(-n4cccn4)ccc3)ccc2)n1.Cn1c2ccccc2c2ccccc21.Cn1c2ccccc2c2ccccc21.Cn1c2ccccc2c2cccnc21.Cn1c2ccccc2c2cccnc21.Cn1c2ccccc2c2cccnc21.Cn1ccnc1-c1[c-]c(Oc2[c-]c(-n3cccn3)ccc2)ccc1.Cn1ccnc1-c1[c-]c(Oc2[c-]c(-n3cccn3)ccc2)ccc1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt]
InChIInChI=1S/2C20H16N4O.2C19H14N4O.C19H15N4O.2C13H11N.3C12H10N2.5Pt/c2*1-15-12-16(2)24(22-15)18-7-4-9-20(14-18)25-19-8-3-6-17(13-19)23-11-5-10-21-23;2*1-22-12-10-20-19(22)15-5-2-7-17(13-15)24-18-8-3-6-16(14-18)23-11-4-9-21-23;1-21-11-12-22(15-21)16-5-2-7-18(13-16)24-19-8-3-6-17(14-19)23-10-4-9-20-23;2*1-14-12-8-4-2-6-10(12)11-7-3-5-9-13(11)14;3*1-14-11-7-3-2-5-9(11)10-6-4-8-13-12(10)14;;;;;/h2*3-12H,1-2H3;2*2-12H,1H3;2-12,15H,1H3;2*2-9H,1H3;3*2-8H,1H3;;;;;/q4*-2;-3;;;;;;;4*+2
InChIKeyIPLSKCIBICHCQJ-UHFFFAOYSA-N
MW3485.35 g/mol
LogP33.90
Rot. Bonds20

About bis(3,5-dimethyl-1-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]pyrazole);bis(9-methylcarbazole);bis(1-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]imidazole);1-methyl-3-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-2H-imidazol-2-ide;tris(9-methylpyrido[2,3-b]indole);platinum;tetrakis(platinum(2+))

bis(3,5-dimethyl-1-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]pyrazole);bis(9-methylcarbazole);bis(1-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]imidazole);1-methyl-3-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-2H-imidazol-2-ide;tris(9-methylpyrido[2,3-b]indole);platinum;tetrakis(platinum(2+)) (PubChem CID 157469530) has the molecular formula C159H127N28O5Pt5-3 and a molecular weight of 3485.35 g/mol. Its IUPAC name is bis(3,5-dimethyl-1-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]pyrazole);bis(9-methylcarbazole);bis(1-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]imidazole);1-methyl-3-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-2H-imidazol-2-ide;tris(9-methylpyrido[2,3-b]indole);platinum;tetrakis(platinum(2+)).

Molecular Properties

Compound Namebis(3,5-dimethyl-1-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]pyrazole);bis(9-methylcarbazole);bis(1-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]imidazole);1-methyl-3-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-2H-imidazol-2-ide;tris(9-methylpyrido[2,3-b]indole);platinum;tetrakis(platinum(2+))
PubChem CID157469530
Molecular FormulaC159H127N28O5Pt5-3
Molecular Weight3485.35 g/mol
Exact Mass3482.88
IUPAC Namebis(3,5-dimethyl-1-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]pyrazole);bis(9-methylcarbazole);bis(1-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]imidazole);1-methyl-3-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-2H-imidazol-2-ide;tris(9-methylpyrido[2,3-b]indole);platinum;tetrakis(platinum(2+))
SMILESCN1C=CN(c2[c-]c(Oc3[c-]c(-n4cccn4)ccc3)ccc2)[CH-]1.Cc1cc(C)n(-c2[c-]c(Oc3[c-]c(-n4cccn4)ccc3)ccc2)n1.Cc1cc(C)n(-c2[c-]c(Oc3[c-]c(-n4cccn4)ccc3)ccc2)n1.Cn1c2ccccc2c2ccccc21.Cn1c2ccccc2c2ccccc21.Cn1c2ccccc2c2cccnc21.Cn1c2ccccc2c2cccnc21.Cn1c2ccccc2c2cccnc21.Cn1ccnc1-c1[c-]c(Oc2[c-]c(-n3cccn3)ccc2)ccc1.Cn1ccnc1-c1[c-]c(Oc2[c-]c(-n3cccn3)ccc2)ccc1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt]
InChIInChI=1S/2C20H16N4O.2C19H14N4O.C19H15N4O.2C13H11N.3C12H10N2.5Pt/c2*1-15-12-16(2)24(22-15)18-7-4-9-20(14-18)25-19-8-3-6-17(13-19)23-11-5-10-21-23;2*1-22-12-10-20-19(22)15-5-2-7-17(13-15)24-18-8-3-6-16(14-18)23-11-4-9-21-23;1-21-11-12-22(15-21)16-5-2-7-18(13-16)24-19-8-3-6-17(14-19)23-10-4-9-20-23;2*1-14-12-8-4-2-6-10(12)11-7-3-5-9-13(11)14;3*1-14-11-7-3-2-5-9(11)10-6-4-8-13-12(10)14;;;;;/h2*3-12H,1-2H3;2*2-12H,1H3;2-12,15H,1H3;2*2-9H,1H3;3*2-8H,1H3;;;;;/q4*-2;-3;;;;;;;4*+2
InChIKeyIPLSKCIBICHCQJ-UHFFFAOYSA-N
XLogP33.90
TPSA276.33 Ų
H-Bond Donors
H-Bond Acceptors33
Rotatable Bonds20
Heavy Atoms197
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003485.35
LogP ≤ 533.90
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1033

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze bis(3,5-dimethyl-1-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]pyrazole);bis(9-methylcarbazole);bis(1-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]imidazole);1-methyl-3-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-2H-imidazol-2-ide;tris(9-methylpyrido[2,3-b]indole);platinum;tetrakis(platinum(2+)) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of bis(3,5-dimethyl-1-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]pyrazole);bis(9-methylcarbazole);bis(1-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]imidazole);1-methyl-3-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-2H-imidazol-2-ide;tris(9-methylpyrido[2,3-b]indole);platinum;tetrakis(platinum(2+))?
The IUPAC name of bis(3,5-dimethyl-1-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]pyrazole);bis(9-methylcarbazole);bis(1-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]imidazole);1-methyl-3-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-2H-imidazol-2-ide;tris(9-methylpyrido[2,3-b]indole);platinum;tetrakis(platinum(2+)) (CID 157469530) is bis(3,5-dimethyl-1-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]pyrazole);bis(9-methylcarbazole);bis(1-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]imidazole);1-methyl-3-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-2H-imidazol-2-ide;tris(9-methylpyrido[2,3-b]indole);platinum;tetrakis(platinum(2+)).
What is the SMILES notation for bis(3,5-dimethyl-1-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]pyrazole);bis(9-methylcarbazole);bis(1-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]imidazole);1-methyl-3-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-2H-imidazol-2-ide;tris(9-methylpyrido[2,3-b]indole);platinum;tetrakis(platinum(2+))?
The canonical SMILES for bis(3,5-dimethyl-1-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]pyrazole);bis(9-methylcarbazole);bis(1-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]imidazole);1-methyl-3-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-2H-imidazol-2-ide;tris(9-methylpyrido[2,3-b]indole);platinum;tetrakis(platinum(2+)) is CN1C=CN(c2[c-]c(Oc3[c-]c(-n4cccn4)ccc3)ccc2)[CH-]1.Cc1cc(C)n(-c2[c-]c(Oc3[c-]c(-n4cccn4)ccc3)ccc2)n1.Cc1cc(C)n(-c2[c-]c(Oc3[c-]c(-n4cccn4)ccc3)ccc2)n1.Cn1c2ccccc2c2ccccc21.Cn1c2ccccc2c2ccccc21.Cn1c2ccccc2c2cccnc21.Cn1c2ccccc2c2cccnc21.Cn1c2ccccc2c2cccnc21.Cn1ccnc1-c1[c-]c(Oc2[c-]c(-n3cccn3)ccc2)ccc1.Cn1ccnc1-c1[c-]c(Oc2[c-]c(-n3cccn3)ccc2)ccc1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt].
What is the InChIKey of bis(3,5-dimethyl-1-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]pyrazole);bis(9-methylcarbazole);bis(1-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]imidazole);1-methyl-3-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-2H-imidazol-2-ide;tris(9-methylpyrido[2,3-b]indole);platinum;tetrakis(platinum(2+))?
The InChIKey is IPLSKCIBICHCQJ-UHFFFAOYSA-N. The full InChI is InChI=1S/2C20H16N4O.2C19H14N4O.C19H15N4O.2C13H11N.3C12H10N2.5Pt/c2*1-15-12-16(2)24(22-15)18-7-4-9-20(14-18)25-19-8-3-6-17(13-19)23-11-5-10-21-23;2*1-22-12-10-20-19(22)15-5-2-7-17(13-15)24-18-8-3-6-16(14-18)23-11-4-9-21-23;1-21-11-12-22(15-21)16-5-2-7-18(13-16)24-19-8-3-6-17(14-19)23-10-4-9-20-23;2*1-14-12-8-4-2-6-10(12)11-7-3-5-9-13(11)14;3*1-14-11-7-3-2-5-9(11)10-6-4-8-13-12(10)14;;;;;/h2*3-12H,1-2H3;2*2-12H,1H3;2-12,15H,1H3;2*2-9H,1H3;3*2-8H,1H3;;;;;/q4*-2;-3;;;;;;;4*+2.
What are the key properties of bis(3,5-dimethyl-1-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]pyrazole);bis(9-methylcarbazole);bis(1-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]imidazole);1-methyl-3-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-2H-imidazol-2-ide;tris(9-methylpyrido[2,3-b]indole);platinum;tetrakis(platinum(2+))?
bis(3,5-dimethyl-1-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]pyrazole);bis(9-methylcarbazole);bis(1-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]imidazole);1-methyl-3-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-2H-imidazol-2-ide;tris(9-methylpyrido[2,3-b]indole);platinum;tetrakis(platinum(2+)) has a molecular weight of 3485.35 g/mol, XLogP of 33.90, 20 rotatable bonds, 0 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for bis(3,5-dimethyl-1-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]pyrazole);bis(9-methylcarbazole);bis(1-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]imidazole);1-methyl-3-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-2H-imidazol-2-ide;tris(9-methylpyrido[2,3-b]indole);platinum;tetrakis(platinum(2+)) is sourced from PubChem (CID 157469530), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).